ATRN-119

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameATRN-119
Drug Alias NameAtaxia telangiectasia and Rad3-related protein inhibitors(Atrin Pharmaceuticals)ATRN-119
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATR inhibitors
TargetsSerine-protein kinase ATR
Therapy Area/IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Solid tumoursProstatic Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAprea Therapeutics Ab
China Registration ClassN/A

Develop Information

Active CompaniesAprea Therapeutics Ab
Inactive CompaniesN/A
Active IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Solid tumoursProstatic Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A